Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Deep vein thrombosis | 66 | 25 | |
Pulmonary embolism | 54 | 23 | |
Atrial fibrillation | 35 | 5 | |
Blood clot | 9 | 0 | |
Antiphospholipid antibody syndrome | 7 | 2 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Bruising | 5 | |
Headaches | 2 | |
Nosebleeds (epistaxis) | 2 | |
Bleeding gums | 1 | |
Blood pooling in limbs | 1 | |
Burning sensation in eyes | 1 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 1 | |
Moderate | 5 | |
Mild | 14 | |
None | 45 |